Literature DB >> 16499833

Medication-overuse headache: description, treatment, and relapse prevention.

Licia Grazzi1, Frank Andrasik.   

Abstract

Medication-overuse headache (MOH) has increasingly become a focus within the field of headache. The biologic and physiopathologic origin for MOH likely resides in receptor physiology, but it also is probable that the initiation and sustaining dynamics of this pathologic condition involve several other factors. Not all patients with frequent headache eventually overuse their medications, but when it happens (the percentage is approximately 1%), the diagnosis of MOH is clinically important because patients rarely respond to preventive medications while overusing acute medications. Properly treating medication overuse and preventing relapse require recognition of the different factors that contribute to its development and perpetuation, including some behaviors and psychologic elements that are important in sustaining the overuse of medication. The problem regarding the diagnosis, the classification, and clinical aspects of MOH is reviewed in this article. The different therapeutic approaches, initial outcomes, and long-term durability of treatment also are discussed.

Entities:  

Mesh:

Year:  2006        PMID: 16499833     DOI: 10.1007/s11916-006-0012-4

Source DB:  PubMed          Journal:  Curr Pain Headache Rep        ISSN: 1534-3081


  45 in total

1.  Debate: analgesic overuse is a cause, not consequence, of chronic daily headache. Analgesic overuse is not a cause of chronic daily headache.

Authors:  David W Dodick
Journal:  Headache       Date:  2002-06       Impact factor: 5.887

2.  Medication overuse headache: rates and predictors for relapse in a 4-year prospective study.

Authors:  Z Katsarava; M Muessig; A Dzagnidze; G Fritsche; H C Diener; V Limmroth
Journal:  Cephalalgia       Date:  2005-01       Impact factor: 6.292

3.  Kaplan Award 1998. Epidemiology of chronic daily headache in the general population.

Authors:  J Castillo; P Muñoz; V Guitera; J Pascual
Journal:  Headache       Date:  1999-03       Impact factor: 5.887

4.  Quality-of-life differences between patients with episodic and transformed migraine.

Authors:  D M Meletiche; J H Lofland; W B Young
Journal:  Headache       Date:  2001-06       Impact factor: 5.887

5.  The Migraine Disability Assessment (MIDAS) questionnaire: translation and reliability of the Italian version.

Authors:  D D'Amico; P Mosconi; S Genco; S Usai; A M Prudenzano; L Grazzi; M Leone; F M Puca; G Bussone
Journal:  Cephalalgia       Date:  2001-12       Impact factor: 6.292

6.  An international study to assess reliability of the Migraine Disability Assessment (MIDAS) score.

Authors:  W F Stewart; R B Lipton; J Whyte; A Dowson; K Kolodner; J N Liberman; J Sawyer
Journal:  Neurology       Date:  1999-09-22       Impact factor: 9.910

7.  Drug induced refractory headache--clinical features and management.

Authors:  N T Mathew; R Kurman; F Perez
Journal:  Headache       Date:  1990-10       Impact factor: 5.887

8.  Analgesic use: a predictor of chronic pain and medication overuse headache: the Head-HUNT Study.

Authors:  J-A Zwart; G Dyb; K Hagen; S Svebak; J Holmen
Journal:  Neurology       Date:  2003-07-22       Impact factor: 9.910

9.  Comprehensive inpatient treatment for intractable migraine: a prospective long-term outcome study.

Authors:  A E Lake; J R Saper; S F Madden; C Kreeger
Journal:  Headache       Date:  1993-02       Impact factor: 5.887

10.  Longterm prognosis of analgesic withdrawal in patients with drug-induced headaches.

Authors:  C Baumgartner; P Wessely; C Bingöl; J Maly; F Holzner
Journal:  Headache       Date:  1989-09       Impact factor: 5.887

View more
  9 in total

Review 1.  Practical considerations for the treatment of elderly patients with migraine.

Authors:  Paola Sarchielli; Maria Luisa Mancini; Paolo Calabresi
Journal:  Drugs Aging       Date:  2006       Impact factor: 3.923

2.  Behavioral plus pharmacological treatment versus pharmacological treatment only for chronic migraine with medication overuse after day-hospital withdrawal.

Authors:  Licia Grazzi; Susanna Usai; Anna Prunesti; Gennaro Bussone; Frank Andrasik
Journal:  Neurol Sci       Date:  2009-05       Impact factor: 3.307

Review 3.  Disability in chronic daily headache: state of the art and future directions.

Authors:  Domenico D'Amico; L Grazzi; S Usai; A Raggi; M Leonardi; G Bussone
Journal:  Neurol Sci       Date:  2011-05       Impact factor: 3.307

Review 4.  Behavioral medicine for migraine and medication overuse headache.

Authors:  Frank Andrasik; Dawn C Buse; Licia Grazzi
Journal:  Curr Pain Headache Rep       Date:  2009-06

Review 5.  Headache with medication overuse: treatment strategies and proposals of relapse prevention.

Authors:  Licia Grazzi; Frank Andrasik; Susanna Usai; Gennaro Bussone
Journal:  Neurol Sci       Date:  2008-05-16       Impact factor: 3.307

Review 6.  Behavioural approach to the "difficult" patient.

Authors:  Licia Grazzi
Journal:  Neurol Sci       Date:  2008-05       Impact factor: 3.307

Review 7.  When should "chronic migraine" patients be considered "refractory" to pharmacological prophylaxis?

Authors:  Domenico D'Amico; Massimo Leone; Licia Grazzi; Gennaro Bussone
Journal:  Neurol Sci       Date:  2008-05       Impact factor: 3.307

8.  In-patient vs. day-hospital withdrawal treatment for chronic migraine with medication overuse and disability assessment: results at one-year follow-up.

Authors:  Licia Grazzi; Frank Andrasik; Susanna Usai; Gennaro Bussone
Journal:  Neurol Sci       Date:  2008-05       Impact factor: 3.307

9.  Biofeedback in the prophylactic treatment of medication overuse headache: a pilot randomized controlled trial.

Authors:  Marialuisa Rausa; Daniela Palomba; Sabina Cevoli; Luana Lazzerini; Elisa Sancisi; Pietro Cortelli; Giulia Pierangeli
Journal:  J Headache Pain       Date:  2016-09-22       Impact factor: 7.277

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.